Ralitsa Larsen, Author at Precision Value & Health

AJMC Center for Biosimilars: How to Encourage Biosimilar Uptake, Cultural Changes and Formulary Placement

Ralitsa Larsen2020-10-23T18:17:30+00:00Events|

A deep dive into the future of biosimilars: In this In this exclusive 2-part video interview for AJMC’s Center for Biosimilars, editor Matthew Gavidia speaks with PRECISIONvalue’s Ryan Cox to discuss what employers can do to encourage biosimilar uptake, the cultural changes that are needed to make it happen, and whether midsize employers can participate in payer discussions on formulary placement.

(more…)

Driving Value in the Era of Biosimilars – What Payers & Manufacturers Can Do to Support Employers

Ralitsa Larsen2020-11-10T17:13:40+00:00Thought Leadership|

The complexities and misaligned incentives within our healthcare system have affected the pace of biosimilar adoption in the US.

(more…)

Charting A Course Into The Unknown: Manufacturer Considerations In Gene Therapy

Ralitsa Larsen2020-11-10T17:13:08+00:00Thought Leadership|

The gene therapy market is still in its infancy but poised for significant growth, with an approximate 25% increase in therapies in the pipeline as compared to 2018. However, the launch of a gene therapy is an event with limited case examples to follow and numerous unique considerations.

(more…)

How the value of innovation will be redefined in 2021

Ralitsa Larsen2020-10-14T19:29:24+00:00Thought Leadership|

The value of innovation in 2021: There will be a growing need for innovators to justify the value of their products to multiple stakeholders next year, with an increased focus on a treatment’s societal value, how innovation interacts with digital technologies, and whether new innovations are able to reduce existing health outcome inequalities.

(more…)

The Importance of Crisis Management–Social Networking Strategies for Behavior Change in Vaccine Adoption

Ralitsa Larsen2020-10-14T19:27:22+00:00Thought Leadership|

The Director-General of the World Health Organization recently declared that regarding COVID-19, “We’re not just fighting an epidemic; we’re fighting an infodemic.”

(more…)

On-demand Webinar: Wish I Knew Then What I Know Now–How Cell and Gene Therapies are Reshaping Commercialization Strategies

Ralitsa Larsen2020-11-19T15:33:41+00:00Events|

In this webinar, Carolyn Morgan of PRECISIONeffect moderates an expert panel exploring the challenges of commercializing a cell or gene therapy from industry trailblazers.

(more…)

Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model

Ralitsa Larsen2020-10-02T17:14:34+00:00Thought Leadership|

The Centers for Medicare & Medicaid Services announced its third annual evaluation report of the Oncology Care Model in July 2020, covering performance periods 1-3 activities and results. Precision’s Maureen Hennessey and Larry Blandford update observations from earlier reports, focusing on potential opportunities for improvement in utilization and other performance metrics including end-of-life care, depression and pain/oncology care integration, and application of continuous quality improvement methods.

(more…)

Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes

Ralitsa Larsen2020-09-24T20:50:43+00:00Thought Leadership|

By Meena Venkatachalam, MSc , Jason Shafrin, PhD

The COVID-19 pandemic has put the inequality in health outcomes in the United States center stage. What can the healthcare industry do to begin to address disparities in health outcomes? Precision’s Jason Shafrin and Meena Venkatachalam discuss how improving the representativeness of clinical trials and updating our value assessment frameworks can help improve health outcomes for the most disadvantaged in our society.

(more…)

Experts Discuss How Expanding Traditional Value Frameworks Can Address Inequities in Health Outcomes

Ralitsa Larsen2020-09-14T22:11:52+00:00Events|

Expanding traditional value frameworks to include inequality and the factors that contribute to inequality is the first step to addressing disparities in health outcomes. In this exclusive AMJC video interview by Matthew Gavidia, PRECISIONheor’s Jason Shafrin and Meena Venkatachalam discuss how utilizing multi-criteria decision analysis and distributional cost effect analysis can assist in deriving data and taking action on these issues.

(more…)

Four Ways Pharma Can Use Digital To Keep Patients The Central Focus

Ralitsa Larsen2020-09-14T21:48:41+00:00Thought Leadership|

In 2001 the Institute of Medicine named patient centered care one of six keys to delivering high-quality care. How can pharma companies keep patients center stage while in the midst of a digital transformation? Precision’s Marty Samples discusses the four fundamentals of patient-centered care and how pharma marketers can use digital to execute on them.

(more…)

NEWS & INSIGHTS

Information and observations on value and health

About Ralitsa Larsen

AJMC Center for Biosimilars: How to Encourage Biosimilar Uptake, Cultural Changes and Formulary Placement

Driving Value in the Era of Biosimilars – What Payers & Manufacturers Can Do to Support Employers

Charting A Course Into The Unknown: Manufacturer Considerations In Gene Therapy

How the value of innovation will be redefined in 2021

The Importance of Crisis Management–Social Networking Strategies for Behavior Change in Vaccine Adoption

On-demand Webinar: Wish I Knew Then What I Know Now–How Cell and Gene Therapies are Reshaping Commercialization Strategies

Value Transformation: Observations on the Third Annual Evaluation Report of the Oncology Care Model

Contributor: Steps Health Professionals Can Take to Reduce Inequality in Health Outcomes

Experts Discuss How Expanding Traditional Value Frameworks Can Address Inequities in Health Outcomes

Four Ways Pharma Can Use Digital To Keep Patients The Central Focus